Mr. Mark Cheong Wing Loong
Mark Cheong is a Lecturer at the School of Pharmacy, Monash University Malaysia. His area of research is on the development and delivery of healthcare services in low and middle-income countries, with an emphasis on neurological diseases. Mark received his MPharm and MBA from the University of Strathclyde and his MA (Health Research - Public Health) from Lancaster University. He is a pharmacist registered with the Pharmacy Board of Malaysia and previously practiced as a clinical pharmacist at the Institute of Neurosciences, Kuala Lumpur General Hospital. He is also a board-certified pharmacotherapy specialist (BCPS) with the Board of Pharmacy Specialties, USA. Prior to joining academia, he led teams in the design, development, and delivery of healthcare services in both the public and private healthcare sector in Malaysia.
- Master of Arts (Health Research - Public Health), Lancaster University, 2015
- Master of Business Administration, University of Strathclyde, 2011
- Master of Pharmacy, University of Strathclyde, 2006
1. Clinical Pharmacy
2. Public Health
3. Quality Outcomes in Healthcare
4. Healthcare Management
Pharmacy Board of Malaysia
Malaysian Society of Neurosciences
International Parksinson and Movement Disorder Society
Member, since 2016
Malaysian Pharmaceutical Society
Facilitator, Since December 2015
Board Certified Pharmacotherapy Specialist, 2012-2019
Board of Pharmacy Specialties
Member, Since May 2014
Nicotine Addiction Research & Collaborating Centre
My primary research interest is on the development and delivery of healthcare services in low and middle-income countries, with an emphasis on neurological diseases. I am interested in working on the epidemiology of diseases in LMICs, the identification of unmet patient needs, and the barriers and facilitators of developing and delivering culturally-relevant healthcare services. I am also interested in research on how local communities use and engage with healthcare services.
Current Research Projects
- Supportive Care for Multiple Sclerosis Patients in Malaysia
- Public Usage of Community Pharmacies for Self-Management of Pain
Peer Reviewed Journal Papers
Cheong, W.L., Mohan, D., Warren, N., & Reidpath, D. D. (2019). Living with a neglected neurological disease: A qualitative study of patients with multiple sclerosis in Malaysia. Disability and Rehabilitation. doi:10.1080/09638288.2019.1695000
Cheong, W.L., Mohan, D., Warren, N., & Reidpath, D. D. (2019). Accessing Palliative Care for Multiple Sclerosis: A Qualitative Study of a Neglected Neurological Disease. Multiple Sclerosis and Related Disorders, 35. doi: 10.1016/j.msard.2019.07.009
Cheong, W.L., Mohan, D., Warren, N., & Reidpath, D. D. (2019). Response to de Groot ‘There is an urgent need for palliative care specialists in MS – Commentary’. (Epub ahead of print). doi: 10.1177/1352458519876697
Yoon, E.L., Cheong, W.L. (2019). Adherence to Oral Disease-Modifying Therapy in Multiple Sclerosis Patients: A Systematic Review. Multiple Sclerosis and Related Disorders. doi: 10.1016/j.msard.2018.12.025
Cheong, W. L., Mohan, D., Warren, N., & Reidpath, D. D. (in press). Palliative Care Research in the Asia Pacific Region: A Systematic Review and Bibliometric Analysis of Peer Reviewed Publications. Journal of Palliative Medicine.
Cheong, W. L., Mohan, D., Warren, N., & Reidpath, D. D. (2018). Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease. Frontiers in neurology, 9, 432. doi:10.3389/fneur.2018.00432
Cheong, W. L., & Reidpath, D. D. (2017). Palliative Care in Neurology. The Lancet Neurology, 16, 11. doi: 10.1016/S1474-4422(17)30321-6
Cheong, W. L. (2017) A descriptive study of a pharmacist medication adherence program for patients with multiple sclerosis using interferon beta. Journal of Pharmacy Practice and Research 43:655-61
Cheong, W. L. (2016). Malaysian Health Care System Still Needs Work. Health Affairs, 35(8), p. 1547
Shanthi Viswanathan, Masita Arip, Norhazlin Mustafa, Mark Cheong Wing Loong et al., “The Frequency of Anti-Aquaporin-4 Ig G Antibody in Neuromyelitis Optica and Its Spectrum Disorders at a Single Tertiary Referral Center in Malaysia,” Multiple Sclerosis International, vol. 2014, Article ID 568254, 10 pages, 2014. doi:10.1155/2014/568254
Conference Proceedings (Refereed Only)
Cheong, W.L., Reidpath, D.D. “The Absence of Epidemiological Data of Multiple Sclerosis in the Pacific, South Asia, South East Asia, and East Asian Regions.” Pan-Asian Committee for Treatment and Research in Multiple Sclerosis. 23 November 2017. Ho Chih Minh City, Vietnam
Cheong, W.L. "The Effectiveness of Oral Methylcobalamin for the Treatment of Mild-Moderate Peripheral Neuropathy." Malaysian Pharmaceutical Society Scientific Conference. November 2017. Penang, Malaysia
Cheong, W.L., Tee, H.Y., Njord, L., Ong, K.L., Ng, E.K., Gan, W.H., Aakhus, L.A., Krishnan, M., Ramirez, S.B.S. "Reduction in Catheter-Related Blood Stream Infections in DVA Dialysis Facilities Through a Systematic Infection Control Reduction Program." Oral Presentation. 32nd Annual Congress of the Malaysian Society of Nephrology. 30th April 2016. Malaysia
Cheong, W.L., Lim, K.K., Mai, C.W., Chong, D. “Perceptions of Young Pharmacists in Malaysia Towards the Pharmacy Profession and the Malaysian Pharmacist Professional Society.” Oral presentation. Federation of Asian Pharmaceutical Associations Congress. 13 September 2012. Bali, Indonesia.
Cheong, W.L. and Thong, C. N. “Effects of pharmacist-managed medication therapy adherence clinic on patients using interferon-beta in multiple sclerosis: a non-experimental, observational study.”Poster presentation. Asian Conference of Clinical Pharmacy. 7 July 2012. Hong Kong.
Local Presentation (Top 20)
Mark Cheong. (24 April 2015) “Cash and Caring: Entrepreneurship in Healthcare Professions.”Presented at International Medical Education Conference 2015. Kuala Lumpur.
International Presentation (Top 20)
“Creating an Intelligent Regional Referral Hospital while Remaining Competitive at UM Specialist Centre.” Presented at 3rd Annual Hospital Efficiency and Quality Asia Summit 2014. Kuala Lumpur.
"Clinical Pharmacy Services for Better Outcomes." Presented at 2nd Philippines Pharmacy Summit 2013. Manila.
"Evolving role of Clinical Pharmacy." Presented at Good Pharmacy Practice Symposium 2013. Jakarta.